News

STriTuVaD-Consortium-ArchivelFarma
ArchivelGeneralPress release
22/10/2021

The STriTuVaD Consortium is proud to announce the recruitment of the First Patient in the STriTuVaD Clinical Trial of RUTI® Vaccine for Tuberculosis (TB)

The Spanish biotech company Archivel Farma has officially begun the clinical trial of its therapeutic…
Read More
ArchivelPress releaseResearch
08/04/2020

Archivel Farma’s RUTI® vaccine to start a clinical trial to increase the immunity of healthcare professionals exposed to the risk of COVID-19

The clinical trial will be carried out at the Germans Trias i Pujol Hospital in…
Read More
General
05/11/2019

Extension of the authorization for the manufacture of medicines

As of 30th October 2019, Archivel Farma has obtained from the Spanish Health Authority the authorization…
Read More
Research
20/02/2019

Archivel Farma at the annual TBVI meeting

On January 29, Archivel Farma, represented by its CEO, Olga Rúe, and Dr. Pere Joan…
Read More
EU Project
04/02/2019

Inauguration meeting of STriTuVaD project

Olga Rue, CEO of Archivel Farma, and Dr Pere Joan Cardona, Scientific advisor of the…
Read More
Research
15/01/2019

Archivel participates in the STriTuVaD consortium

Archivel Farma is one of the eight partners of STriTuVad consortium, whose overall goal is…
Read More
Archivel
23/03/2018

Archivel Farma launches its new website on the World TB Day 2018

Archivel Farma has decide to launch its new website to coincide with the World TB…
Read More
Press release
20/03/2018

Archivel Farma and Laboratorios Silanes to collaborate in the development of the anti-tuberculosis vaccine RUTI® in México

RUTI® is the most promising therapeutic vaccine among the dozen projects that are currently being…
Read More
Research
02/02/2018

Archivel Farma participated in the TBVI Symposium on therapeutic vaccination

Dr Pere-Joan Cardona, inventor of RUTI® vaccine and Scientific Advisor of Archivel Farma, and Olga…
Read More
Press releaseResearch
19/10/2017

The RUTI® vaccine for the treatment of tuberculosis, presented to the WHO experts

Archivel Farma, owner of the vaccine, has started a Phase IIa clinical trial to assess…
Read More

Archivel on the media

TV3, QuèQuiCom
2016

TV3, Trenta Minuts
2011